What are the new treatments for Muscular Polyarteritis Nodosa (m-PAN) with fasciitis?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18740175
Cited by: 0

Abstract

Biologic agents like tocilizumab show promise for refractory muscular polyarteritis nodosa, though corticosteroids and cyclophosphamide remain the treatment mainstay.

Fields of Study & Subjects

Vasculitis and related conditions Autoimmune and Inflammatory Disorders Otitis Media and Relapsing Polychondritis

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
23 February 2026
Language
EN